Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GN10017 Wogonin

    汉黄芩素

    A flavonoid with anti-inflammatory and antitumor activities
  3. GN10076 Geniposidic acid

    京尼平苷酸

    An iridoid glycoside with diverse biological activities
  4. GN10740 Tetrahydropalmatine

    延胡索乙素; DL-Tetrahydropalmatine

    四氢巴马汀具有镇痛作用。
  5. GN10189 Cinobufagin

    华蟾蜍精; Cinobufagine

    A cardiotonic steroid with diverse biological activities
  6. GC15878 Atractyloside Dipotassium Salt

    苍术苷钾盐

    Inhibitor of ADP/ATP translocases
  7. GC11993 PAC-1

    Procaspase activating compound 1

    An in vitro procaspase-3 activator
  8. GC12961 Apicidin

    OSI 2040

    A cell-permeable HDAC inhibitor

  9. GC11334 Romidepsin (FK228, depsipeptide)

    罗米地辛; FK 228; FR 901228; NSC 630176

    A class I HDAC inhibitor
  10. GC12257 Panobinostat (LBH589)

    帕比司他; LBH589; NVP-LBH589

    A pan-HDAC inhibitor
  11. GC13601 Everolimus (RAD001)

    依维莫司; RAD001; SDZ-RAD

    依维莫司 (RAD001) 是一种具有口服活性的雷帕霉素衍生物,可抑制 Ser/Thr 激酶 mTOR(雷帕霉素的哺乳动物靶标)。
  12. GC11510 HA14-1

    乙基-2-氨基-6-溴-4-(1-氰基-2-乙氧基-2-甲酰)-4H-苯并呋喃-3-羧酸

    A Bcl-2 inhibitor
  13. GC15031 Rapamycin (Sirolimus)

    雷帕霉素; 西罗莫司; Sirolimus; AY-22989

    Rapamycin曾经被用作抗真菌抗生素。
  14. GC11625 Entinostat (MS-275,SNDX-275)

    恩替诺特; MS-275; SNDX-275

    A histone deacetylase inhibitor
  15. GA11219 Tos-Arg-OMe·HCl

    NA-P-甲苯磺酰-L-精氨酸甲酯盐酸盐

    Tos-Arg-OMe.HCl 是后期促进复合物/环体(APC/C 或 APC)的抑制剂,它与 APC/C 结合并阻止其被 Cdc20 和 Cdh1 激活,产生有丝分裂停滞。 Tos-Arg-OMe.HCl 不具有细胞渗透性。
  16. GC15066 Z-FA-FMK

    半胱氨酸蛋白酶抑制剂,Z-FA-FMK, Z-Phe-Ala-fluoromethyl ketone, Z-Phe-Ala-FMK, Zfa-FMK, Z-Phe-Ala-CH2F, Cathepsin B, Caspase Inhibitor

    An inhibitor of cysteine proteases, including cathepsin B
  17. GC11713 Q-VD(OMe)-OPh

    Q-VD(OMe)-OPh

    Pan-caspase inhibitor
  18. GC15089 Carfilzomib (PR-171)

    卡非佐米; PR-171

    A proteasome inhibitor
  19. GC11965 (±)-Huperzine A

    (±)-石杉碱甲

    A neuroprotective AChE inhibitor
  20. GC10160 Apoptosis Inhibitor

    2,2′-亚甲基双(1,3-环己二酮)

    A cell-permeable inhibitor of caspase-3 activation
  21. GC11718 Caspase-3/7 Inhibitor I An isatin sulfonamide-based inhibitor of caspase-3 and caspase-7
  22. GC12190 Z-WEHD-FMK

    N-[苄氧羰基]-L-色氨酰-L-ALPHA-谷氨酰-N-[(1S)-3-氟-1-(2-甲氧基-2-氧代乙基)-2-氧代丙基]-L-组胺酰胺甲基酯,Z-WEHD-FMK, Caspase-5 Inhibitor (fluoromethylketone)

    Z-WEHD-FMK 是一种有效的、细胞渗透性和不可逆的 caspase-1/5 抑制剂。 Z-WEHD-FMK 还表现出对组织蛋白酶 B 活性的强大抑制作用 (IC50=6 μM)。 Z-WEHD-FMK 可用于研究细胞凋亡的证据。
  23. GC13413 Z-VEID-FMK

    Caspase-6 inhibitor (fluoromethylketone),Benzyloxycarbonyl-Val-Glu(OMe)-Ile-​Asp(OMe)-fluoromethylketone

    Caspase-6抑制剂
  24. GC11218 Z-VDVAD-FMK

    Z-VDVAD-fluoromethylketone, Caspase-2 Inhibitor (fluoromethylketone),Z-Val-Asp(OMe)-Val-Ala-Asp(OMe)-FMK

    Z-VDVAD-FMK 是一种特殊的 caspase-2 抑制剂。 Z-VDVAD-FMK 减少洛伐他汀诱导的细胞凋亡。
  25. GC16744 Z-DQMD-FMK

    Z-DQMD-FMK,Benzyloxycarbonyl-Asp(OMe)-Gln-Met-​Asp(OMe)-fluoromethylketone

    Caspase-3 inhibitor,cell-permeable
  26. GC12287 Z-DEVD-FMK

    CASPASE-3抑制剂,Caspase-3 Inhibitor II,Z-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-FMK

    Z-DEVD-FMK是一种特异性的不可逆的半胱氨酸-天冬氨酸蛋白酶3(caspase-3)抑制剂,IC50为18μM。
  27. GC15255 Decitabine(NSC127716, 5AZA-CdR)

    地西他滨; 5-Aza-2'-deoxycytidine; 5-AZA-CdR; NSC 127716

    地西他滨(Decitabine, DAC)是一种具有口服生物活性的脱氧胞苷类似物抗代谢物,具有DNA甲基转移酶抑制剂的功能。
  28. GC16774 Boc-D-FMK

    (3S)-3-[[叔丁氧羰基]氨基]-5-氟-4-氧代-戊酸甲酯,Caspase Inhibitor III, Boc-Asp(OMe)-FMK, Boc-D(OMe)-FMK, Caspase3-Inhibitor BOC-D-FMK, Boc-Asp(OMe)-fluoromethylketone

    An irreversible pan-caspase inhibitor
  29. GC16316 Q-VD-OPh hydrate

    (3S)-5-(2,6-二氟苯氧基)-3-[[(2S)-3-甲基-1-氧代-2-[(2-喹啉甲酰基)氨基]丁基]氨基]-4-氧代-戊酸,QVD-OPH; Quinoline-Val-Asp-Difluorophenoxymethylketone

    A caspase inhibitor with low cytotoxicity
  30. GC17644 Bortezomib (PS-341)

    硼替佐米; PS-341; LDP-341; NSC 681239

    Bortezomib (PS-341) 作为一种具有抗肿瘤活性的二肽硼酸蛋白酶体抑制剂,可通过靶向苏氨酸残基,有效抑制Ki为0.6 nM的20S蛋白酶体。

  31. GC10613 Nafamostat Mesylate(FUT-175)

    甲磺酸萘莫司他; FUT-175

    A serine protease inhibitor
  32. GC15083 Celastrol

    雷公藤红素; Celastrol

    Celastrol是一种蛋白酶体抑制剂,有效且优先的抑制纯化的20S蛋白酶体,IC50 为2.5 μM。
  33. GC12070 Ascorbic acid (Standard)

    维生素C

    An electron donor
  34. GP10028 tumor protein p53 binding protein fragment [Homo sapiens]/[Mus musculus]

    H2N-Tyr-Leu-His-Val-Glu-Pro-Glu-Lys-Glu-Val-OH

    P53 binding protein fragment

  35. GP10036 p53 tumor suppressor fragment

    H2N-Lys-Tyr-Met-Cys-Asn-Ser-Ser-Cys-Met-OH

    Regulates cell cycle

Items 2701 to 2734 of 2734 total

per page
  1. 51
  2. 52
  3. 53
  4. 54
  5. 55

Set Descending Direction